• A MSc, PharmD, or PhD in Clinical Pharmacology, Pharmacology, Pharmacokinetics, or a related discipline is required.
• Approximately 2 years of experience in pre-clinical and/or clinical pharmacology in pharma, biotechnology, or consulting.
• Experience in PK and PK/PD data analysis, including noncompartmental analysis and allometric scaling.
• Demonstrated ability to develop and apply mechanistic PK/PD models, particularly PBPK and/or QSP models, to inform drug development decisions.
• Hands-on programming experience in R or a comparable scientific programming language is required; experience with NONMEM, Phoenix WinNonlin, or other PK/PD analysis software is preferred.
• An understanding of antibody therapeutics development and experience in oncology or immunology are considered beneficial.
• A proactive and adaptable approach, with the ability to collaborate across disciplines, prioritize effectively, and communicate scientific findings clearly in writing and verbally.
• Excellent written, verbal, and interpersonal communication skills in English.
• You currently live in the Netherlands, within commuting distance of Utrecht for hybrid working and are available to start no later than January 1, 2027.

The proposed gross annual/monthly base salary range for this position, based on a full-time schedule is:

EUR62,400.00 - 93,600.00

The final salary offer will depend on several factors, including your skills, qualifications, and experience.

In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you become part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:

• Pension
• Health insurance and wellness benefits
• Paid time off
• Employee support programs

Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.

Genmab is an international biotechnology company dedicated to improving patient lives through innovative antibody therapeutics. For 25 years, our collaborative team has developed next-generation antibody technology platforms and leveraged quantitative and data sciences, resulting in a proprietary pipeline that includes bispecific T-cell engagers, antibody-drug conjugates, and next-generation immune checkpoint modulators. By 2030, we aim to transform the lives of those with cancer and other serious diseases with our groundbreaking antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with a presence across North America, Europe, and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year. If the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.